Ultragenyx Pharmaceutical (RARE) Change in Inventory (2018 - 2026)

Ultragenyx Pharmaceutical (RARE) has reported Change in Inventory for 9 consecutive years, with $4.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Inventory rose 300.0% year-over-year to $4.0 million; the TTM figure through Mar 2026 stood at $9.0 million (down 8.87% YoY), while the FY2025 annual figure was $6.0 million, down 45.45% from the prior year.
• Change in Inventory improved to $4.0 million in Q1 2026 per RARE's latest filing, from -$150000.0 in the prior quarter.
• Across five years, Change in Inventory topped out at $5.6 million in Q3 2025 and bottomed at -$445000.0 in Q2 2025.
• Historically, Change in Inventory has averaged $2.2 million across 5 years, with a median of $2.1 million in 2024.
• Annual changes were most pronounced in 2022 — Change in Inventory jumped 1782.98% — and 2025, when it sank 110.78%.
• Ultragenyx Pharmaceutical's Change in Inventory stood at $4.2 million in 2022, then slumped by 51.82% to $2.0 million in 2023, then grew by 11.01% to $2.2 million in 2024, then sank by 106.67% to -$150000.0 in 2025, then jumped by 2766.67% to $4.0 million in 2026.
• Business Quant data shows RARE's Change in Inventory at $4.0 million in Q1 2026, -$150000.0 in Q4 2025, and $5.6 million in Q3 2025.